Trial Profile
A Study to Evaluate the Efficacy of Entecavir for the Treatment of Chronic Hepatitis B with Severe Acute Exacerbation.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Lamivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 02 Dec 2015 New trial record